Data / Drug companies / Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals
Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals: 6 products in the FDA NDC directory, labeler code 12539
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals (labeler code 12539) lists 6 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 5 over the counter drugs, 1 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 20, 2025.
The request: Watch Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals (FDA labeler code 12539): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 12539
- Products in commercial distribution
- 6
- Packages
- 6
- Finished drugs by generic name
- 2
- Prescription products
- 1
- Over the counter products
- 5
- Flagged as original packager
- 6 of 6 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- October 7, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 5 | 83.3% |
| Other unapproved drugs | 1 | 16.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 5 | 83.3% |
| Prescription drugs | 1 | 16.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Guaifenesin, dextromethorphan hbr | 2 | 26 |
| Naphazoline hydrochloride | 1 | 3 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 4 | 66.7% |
| Solution/ drops | 1 | 16.7% |
| Tablet | 1 | 16.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Sigma-1 Agonist | 4 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 4 |
| Histamine-1 Receptor Antagonist | 2 |
| alpha-1 Adrenergic Agonist | 2 |
| Expectorant | 2 |
| Osmotic Laxative | 1 |
| Oxidation-Reduction Agent | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nafasolina | 12539-146 | Solution/ drops | Over the counter monograph drugs | March 20, 2025 |
| NeoTuss Plus | 12539-779 | Liquid | Over the counter monograph drugs | March 6, 2025 |
| NeoTuss S/F Grape-Menthol Flavor | 12539-555 | Liquid | Over the counter monograph drugs | March 6, 2025 |
| NeoTuss Plus | 12539-779 | Liquid | Over the counter monograph drugs | February 28, 2025 |
| NeoTuss S/F Grape-Menthol Flavor | 12539-555 | Liquid | Over the counter monograph drugs | February 28, 2025 |
| Uretron D/S | 12539-144 | Tablet | Other unapproved drugs | October 7, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.